From the Departments of ∗Radiology
†Thoracic Oncosurgery, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital and Institute, Beijing, China.
Received for publication April 19, 2021; accepted July 20, 2021.
Correspondence to: Ying-Shi Sun, MD, Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Rd, Hai Dian District, Beijing 100142, China (e-mail: [email protected]). Jin-Feng Chen, MD, Department of Thoracic Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital and Institute; No. 52 Fu Cheng Rd, Hai Dian District, Beijing 100142, China (e-mail: [email protected]).
The authors declare no conflict of interest.
This work was supported by Beijing Hospitals Authority' Ascent Plan (DFL20191103), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (no ZYLX201803), 2019 SKY Imaging Research Fund of the Chinese International Medical Foundation (project no Z-2014-07-1912), and the third round of public welfare development and reform pilot projects of Beijing Municipal Medical Research Institutes (Beijing Medical Research Institute, 2019-1).
The institutional review board of Peking University Cancer Hospital approved this study. Informed consent was obtained from all prospectively enrolled tuberculosis patients. Informed consent was waivered for retrospectively collected lung cancer patients.